Icon

ZYPITAMAG (nda208379)- (EQ 1MG BASE,EQ 2MG BASE,EQ 4MG BASE)

PITAVASTATIN MAGNESIUM MEDICURE
EQ 1MG BASE,EQ 2MG BASE,EQ 4MG BASE
No Yes
2031-Jan-19 Expired
None None
None No
ZYPITAMAG is an HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet in adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 1MG BASE ** ** - - -
EQ 2MG BASE ** ** - - -
EQ 4MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.